GENE ONLINE|News &
Opinion
Blog

2026-04-08|

Frontiers Research Foundation Endorses Declaration to Advance AI-Ready Data Sharing in One Health Framework

by GOAI
Share To

The Frontiers Research Foundation has endorsed an international Declaration of Intent to promote enhanced data sharing within the One Health framework. This initiative, announced at the One Health Summit, aims to accelerate global collaboration on health and environmental sustainability by emphasizing open science principles. The declaration focuses on fostering interoperable and AI-ready data management strategies that support integrated approaches to addressing health challenges across human, animal, and environmental domains.

The endorsement highlights efforts to streamline data accessibility and usability for researchers worldwide. By advocating for open data sharing practices, the initiative seeks to enable more effective responses to complex global health issues such as zoonotic diseases, antimicrobial resistance, and climate-related health impacts. The declaration aligns with the broader goals of the One Health framework, which emphasizes interconnected solutions for improving public health outcomes while safeguarding ecosystems.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
Study Identifies Active Role of Skin Cells in Rabies Virus Replication and Transmission
2026-04-16
Contractor Fatality Halts Operations at ATEX Resources’ Valeriano Project in Chile
2026-04-15
Dual Inhibition of xCT and GGCT Induces Ferroptosis in Glioblastoma Cells
2026-04-15
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
Scroll to Top